US Patent

US11478456 — Oral pharmaceutical composition comprising Zonisamide and process of preparation thereof

Method of Use · Assigned to Azurity Pharmaceuticals Inc · Expires 2038-08-18 · 12y remaining

Vulnerability score 70/100 Vulnerable — likely target for IPR or design-around

What this patent protects

This patent protects a pharmaceutical composition containing Zonisamide and a process for preparing it, along with one or more acceptable excipients.

USPTO Abstract

The present invention relates to the pharmaceutical composition comprising Zonisamide and one or more pharmaceutically acceptable excipients and also relates to the process for the preparation of the pharmaceutical composition comprising Zonisamide.

Drugs covered by this patent

FDA Patent Use Codes

When a patent is method-of-use, FDA lists it once per applicable indication ("U-code"). Each U-code carves out a specific therapeutic use that generic filers must either license or design around.

Code	Description	Drug
`U-3458`	—

Patent Metadata

Patent number: US11478456
Jurisdiction: US
Classification: Method of Use
Expires: 2038-08-18
Drug substance claim: No
Drug product claim: No
Assignee: Azurity Pharmaceuticals Inc
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.